Literature DB >> 6287461

Purification of polyoma virus medium-size tumor antigen by immunoaffinity chromatography.

G Walter, M A Hutchinson, T Hunter, W Eckhart.   

Abstract

We have used antibodies against the synthetic peptide Lys-Arg-Ser-Arg-His-Phe, corresponding to the six COOH-terminal amino acids of the polyoma virus medium tumor (T) antigen, to purify the medium T antigen by affinity chromatography. Release of the medium T antigen from the anti-peptide antibody was achieved under mild conditions by using a large excess of the peptide in an isotonic buffer at neutral pH containing mixed detergents. This procedure yielded a 2,500-fold purification of the medium T antigen in a single step. The protein kinase activity associated with the medium T antigen was also released and was studied in this active state in solution. Sedimentation analysis showed that the bulk of the purified medium T antigen was in a monomeric form (Mr about 42,000) not associated with protein kinase activity. A small fraction of the medium T antigen was found in a rapidly sedimenting form (Mr about 200,000) that possessed protein kinase activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287461      PMCID: PMC346569          DOI: 10.1073/pnas.79.13.4025

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  New classes of viable deletion mutants in the early region of polyoma virus.

Authors:  B E Griffin; C Maddock
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Protein kinase activity associated with polyoma virus middle T antigen in vitro.

Authors:  A E Smith; R Smith; B Griffin; M Fried
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

3.  Tumor antigens induced by nontransforming mutants of polyoma virus.

Authors:  J Silver; B Schaffhausen; T Benjamin
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

4.  Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product.

Authors:  J G Sutcliffe; T M Shinnick; N Green; F T Liu; H L Niman; R A Lerner
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

5.  Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus.

Authors:  B M Sefton; T Hunter; K Beemon; W Eckhart
Journal:  Cell       Date:  1980-07       Impact factor: 41.582

6.  Early mutants of polyoma virus (dl8 and dl23) with altered transformation properties: is polyoma virus middle T antigen a transforming gene product?

Authors:  B E Griffin; Y Ito; U Novak; N Spurr; S Dilworth; N Smolar; R Pollack; K Smith; D B Rifkin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

7.  An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates.

Authors:  W Eckhart; M A Hutchinson; T Hunter
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

8.  Phosphorylation of polyoma T antigens.

Authors:  B S Schaffhausen; T L Benjamin
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

9.  Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen.

Authors:  G Walter; K H Scheidtmann; A Carbone; A P Laudano; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

10.  Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus.

Authors:  Y Ito; J R Brocklehurst; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  25 in total

1.  Interactions between polyomavirus medium T antigen and three cellular proteins of 88, 61, and 37 kilodaltons.

Authors:  T Grussenmeyer; A Carbone-Wiley; K H Scheidtmann; G Walter
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Stoichiometry of cellular and viral components in the polyomavirus middle-T antigen-tyrosine kinase complex.

Authors:  S H Cheng; P C Espino; J Marshall; R Harvey; A E Smith
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

3.  12-O-tetradecanoylphorbol-13-acetate stimulates phosphorylation of the 58,000-Mr form of polyomavirus middle T antigen in vivo: implications for a possible role of protein kinase C in middle T function.

Authors:  J T Matthews; T L Benjamin
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

4.  Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production.

Authors:  D C Pallas; C Schley; M Mahoney; E Harlow; B S Schaffhausen; T M Roberts
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

5.  Medium tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with 73-kilodalton heat shock protein.

Authors:  G Walter; A Carbone; W J Welch
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

6.  Purified polyoma virus medium T antigen has tyrosine-specific protein kinase activity but no significant phosphatidylinositol kinase activity.

Authors:  W Koch; A Carbone; G Walter
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

7.  Analysis of middle tumor antigen and pp60c-src interactions in polyomavirus-transformed rat cells.

Authors:  J B Bolen; V DeSeau; J O'Shaughnessy; S Amini
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

8.  Antiserum specific for the carboxy terminus of the transforming protein of Rous sarcoma virus.

Authors:  B M Sefton; G Walter
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

9.  Complexes of polyoma virus medium T antigen and cellular proteins.

Authors:  T Grussenmeyer; K H Scheidtmann; M A Hutchinson; W Eckhart; G Walter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  Analysis of pp60c-src protein kinase activity in hamster embryo cells transformed by simian virus 40, human adenoviruses, and bovine papillomavirus 1.

Authors:  S Amini; A M Lewis; M A Israel; J S Butel; J B Bolen
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.